OPEN MARKET SALE AGREEMENTSMOpen Market Sale Agreement • December 18th, 2020 • ImmunoGen, Inc. • Pharmaceutical preparations • New York
ImmunoGen, Inc., a Massachusetts corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s common stock, par value $0.01 per share (the “Common Shares”), having an aggregate offering price of up to $150,000,000 on the terms set forth in this agreement (this “Agreement”).
